These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35575393)
21. The role of cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis. where are we now? Papaliagkas VT Recent Pat CNS Drug Discov; 2013 Apr; 8(1):70-8. PubMed ID: 23489287 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic and Prognostic Laboratory Testing for Alzheimer Disease. Winder Z; Wilcock D; Jicha GA Clin Lab Med; 2020 Sep; 40(3):289-303. PubMed ID: 32718500 [TBL] [Abstract][Full Text] [Related]
23. [Cerebrospinal fluid biomarkers of Alzheimer's disease in current clinical practice]. Magnin E; Popp J Rev Med Suisse; 2016 Apr; 12(515):791-4. PubMed ID: 27276722 [TBL] [Abstract][Full Text] [Related]
24. Salivary lactoferrin as biomarker for Alzheimer's disease: Brain-immunity interactions. Bermejo-Pareja F; Del Ser T; Valentí M; de la Fuente M; Bartolome F; Carro E Alzheimers Dement; 2020 Aug; 16(8):1196-1204. PubMed ID: 32543760 [TBL] [Abstract][Full Text] [Related]
25. Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers. Sjögren M; Andreasen N; Blennow K Clin Chim Acta; 2003 Jun; 332(1-2):1-10. PubMed ID: 12763273 [TBL] [Abstract][Full Text] [Related]
26. [Biomarkers in the cerebrospinal fluid of patients with mild cognitive impairment: a meta-analysis of their predictive capacity for the diagnosis of Alzheimer's disease]. Monge-Argilés JA; Sánchez-Payá J; Muñoz-Ruiz C; Pampliega-Pérez A; Montoya-Gutiérrez J; Leiva-Santana C Rev Neurol; 2010 Feb 16-28; 50(4):193-200. PubMed ID: 20198590 [TBL] [Abstract][Full Text] [Related]
27. Biomarkers of Alzheimer's disease: the present and the future. Lehmann S; Delaby C; Touchon J; Hirtz C; Gabelle A Rev Neurol (Paris); 2013 Oct; 169(10):719-23. PubMed ID: 24021316 [TBL] [Abstract][Full Text] [Related]
29. Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive. Oláh Z; Kálmán J; Tóth ME; Zvara Á; Sántha M; Ivitz E; Janka Z; Pákáski M J Alzheimers Dis; 2015; 44(4):1303-12. PubMed ID: 25428253 [TBL] [Abstract][Full Text] [Related]
30. Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall. Mattsson N; Blennow K; Zetterberg H Clin Chem Lab Med; 2010 May; 48(5):603-7. PubMed ID: 20201744 [TBL] [Abstract][Full Text] [Related]
31. The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau. Hansson O; Batrla R; Brix B; Carrillo MC; Corradini V; Edelmayer RM; Esquivel RN; Hall C; Lawson J; Bastard NL; Molinuevo JL; Nisenbaum LK; Rutz S; Salamone SJ; Teunissen CE; Traynham C; Umek RM; Vanderstichele H; Vandijck M; Wahl S; Weber CJ; Zetterberg H; Blennow K Alzheimers Dement; 2021 Sep; 17(9):1575-1582. PubMed ID: 33788410 [TBL] [Abstract][Full Text] [Related]
32. Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand? Veerabhadrappa B; Delaby C; Hirtz C; Vialaret J; Alcolea D; Lleó A; Fortea J; Santosh MS; Choubey S; Lehmann S Crit Rev Clin Lab Sci; 2020 Mar; 57(2):99-113. PubMed ID: 31661652 [TBL] [Abstract][Full Text] [Related]
33. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease. Christl J; Verhülsdonk S; Pessanha F; Menge T; Seitz RJ; Kujovic M; Höft B; Supprian T; Lange-Asschenfeldt C J Alzheimers Dis; 2019; 72(4):1119-1127. PubMed ID: 31683478 [TBL] [Abstract][Full Text] [Related]
34. Role of biochemical Alzheimer's disease biomarkers as end points in clinical trials. Siemers E; DeMattos RB; May PC; Dean RA Biomark Med; 2010 Feb; 4(1):81-9. PubMed ID: 20387304 [TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Paterson RW; Slattery CF; Poole T; Nicholas JM; Magdalinou NK; Toombs J; Chapman MD; Lunn MP; Heslegrave AJ; Foiani MS; Weston PSJ; Keshavan A; Rohrer JD; Rossor MN; Warren JD; Mummery CJ; Blennow K; Fox NC; Zetterberg H; Schott JM Alzheimers Res Ther; 2018 Mar; 10(1):32. PubMed ID: 29558979 [TBL] [Abstract][Full Text] [Related]
36. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting. Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006 [TBL] [Abstract][Full Text] [Related]
37. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease. Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015 [TBL] [Abstract][Full Text] [Related]